Official technical account: www.fda.gov/science-research/licensing-and-collaboration-opportunities/adaptive-perfusion-novel-in-vitro-drug-release-testing-method-complex-drug-products . Technology Summary defines in-vitro release testing and describes pressure-driven tangential-flow filtration as an alternative to rate-limiting passive dialysis-membrane transport. Development Stage identifies in-vitro data and a prototype. The account links the primary 2021 Journal of Controlled Release paper, PMID 33766693.
Articles by others on the same topic
There are currently no matching articles.